Logo image of RMT

ROYCE MICRO-CAP TRUST INC (RMT) Stock Overview

USA - NYSE:RMT - US7809151043

10.4 USD
-0.11 (-1.05%)
Last: 10/9/2025, 4:10:02 PM
10.4 USD
0 (0%)
After Hours: 10/2/2025, 8:04:00 PM
Fundamental Rating

1

Overall RMT gets a fundamental rating of 1 out of 10. We evaluated RMT against 0 industry peers in the Unkown industry. RMT has a bad profitability rating. Also its financial health evaluation is rather negative. RMT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

RMT had positive earnings in the past year.
RMT had a positive operating cash flow in the past year.
RMT Yearly Net Income VS EBIT VS OCF VS FCFRMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 20M 40M 60M

1.2 Ratios

Industry RankSector Rank
ROA 7.16%
ROE 7.45%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RMT Yearly ROA, ROE, ROICRMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 5 10

1.3 Margins

RMT does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 746.21%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RMT Yearly Profit, Operating, Gross MarginsRMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 200 400 600 800 1K

2

2. Health

2.1 Basic Checks

RMT has more shares outstanding than it did 1 year ago.
RMT has a better debt/assets ratio than last year.
RMT Yearly Shares OutstandingRMT Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M 40M 50M
RMT Yearly Total Debt VS Total AssetsRMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

RMT has an Altman-Z score of 15.35. This indicates that RMT is financially healthy and has little risk of bankruptcy at the moment.
RMT has a debt to FCF ratio of 4.84. This is a neutral value as RMT would need 4.84 years to pay back of all of its debts.
A Debt/Equity ratio of 0.04 indicates that RMT is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.84
Altman-Z 15.35
ROIC/WACCN/A
WACCN/A
RMT Yearly LT Debt VS Equity VS FCFRMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 0.46 indicates that RMT may have some problems paying its short term obligations.
A Quick Ratio of 0.46 indicates that RMT may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46
RMT Yearly Current Assets VS Current LiabilitesRMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200K 400K 600K 800K 1M

0

3. Growth

3.1 Past

The earnings per share for RMT have decreased strongly by -41.04% in the last year.
Looking at the last year, RMT shows a very negative growth in Revenue. The Revenue has decreased by -26.03% in the last year.
EPS 1Y (TTM)-41.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.13%
Revenue 1Y (TTM)-26.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-26.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RMT Yearly Revenue VS EstimatesRMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.16, RMT is valued correctly.
RMT is valuated cheaply when we compare the Price/Earnings ratio to 27.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.16
Fwd PE N/A
RMT Price Earnings VS Forward Price EarningsRMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 132.43
EV/EBITDA N/A
RMT Per share dataRMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

RMT has a Yearly Dividend Yield of 7.31%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.44, RMT pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.31%

5.2 History

RMT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
RMT Yearly Dividends per shareRMT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

53.80% of the earnings are spent on dividend by RMT. This is a bit on the high side, but may be sustainable.
DP53.8%
EPS Next 2YN/A
EPS Next 3YN/A
RMT Yearly Income VS Free CF VS DividendRMT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2023 2024 20M 40M 60M
RMT Dividend Payout.RMT Dividend Payout, showing the Payout Ratio.RMT Dividend Payout.PayoutRetained Earnings

ROYCE MICRO-CAP TRUST INC

NYSE:RMT (10/9/2025, 4:10:02 PM)

After market: 10.4 0 (0%)

10.4

-0.11 (-1.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-26 2025-08-26
Earnings (Next)02-26 2026-02-26
Inst Owners33.72%
Inst Owner Change0%
Ins Owners0.17%
Ins Owner Change-18.94%
Market Cap546.94M
Analysts0
Price TargetN/A
Short Float %0.11%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 7.31%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP53.8%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date09-12 2025-09-12 (0.18)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.16
Fwd PE N/A
P/S 98.72
P/FCF 132.43
P/OCF 132.43
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)0.79
EY7.6%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY0.76%
OCF(TTM)0.08
OCFY0.76%
SpS0.11
BVpS10.55
TBVpS10.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.16%
ROE 7.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 746.21%
GM N/A
FCFM 74.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.84
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 9.99%
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z 15.35
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-26.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-433.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.93%
OCF growth 3YN/A
OCF growth 5YN/A